IP Library › Granted Patent US 7,655,751
Granted Patent B2
US 7,655,751 · App. 10/586,499 · Granted Feb 2, 2010

Epidermal growth factor receptor-derived peptides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,655,751
App. No.
10/586,499
Granted
Feb 2, 2010
Kind
B2
Abstract

The object of the invention is to provide an EGFR-derived peptide useful for EGFR-based immunotherapy. The invention provides an EGFR-derived peptide capable of inducing both cellular and humoral immune responses and mutant peptide thereof and a polypeptide comprising said peptide, a nucleic acid molecule encoding the same, and a pharmaceutical composition comprising the same.

Claims (2)

1. A peptide selected from the group consisting of EGFR 800-809 (SEQ ID NO: 1), EGFR 124-132 (SEQ ID NO: 2), EGFR 54-62 (SEQ ID NO: 3), EGFR 479-488 (SEQ ID NO: 4) or EGFR 1138-1147 (SEQ ID NO: 5).

2. A pharmaceutical composition comprising the peptide of claim 1 , for inducing a cytotoxic T lymphocytes and an antibody specific for said peptide.

Assignments (3)
CHANGE OF ADDRESS OF ASSIGNEE Recorded Oct 16, 2017
From: BRIGHTPATH BIOTHERAPEUTICS CO., LTD.
To: BRIGHTPATH BIOTHERAPEUTICS CO., LTD.
Reel/Frame 044212/0009 →
CHANGE OF NAME Recorded Sep 11, 2017
From: GREEN PEPTIDE CO., LTD.
To: BRIGHTPATH BIOTHERAPEUTICS CO., LTD.
Reel/Frame 043811/0854 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 20, 2006
From: ITOH, KYOGO; SHICHIJO, SHIGEKI
To: GREEN PEPTIDE CO., LTD.
Reel/Frame 018082/0076 →